The p66shc gene expression in peripheral blood monocytes is increased in patients with coronary artery disease

Yoshihiro Noda1, Sho-ichi Yamagishi, Takanori Matsui

  • 1Department of Internal Medicine, Division of Cardio-Vascular Medicine, Kurume, Japan.

Clinical Cardiology
|September 16, 2010
PubMed

Insights

Increased p66(shc) gene expression in peripheral blood monocytes (PBMs) is linked to coronary artery disease (CAD) in Japanese individuals. This finding suggests p66(shc) may serve as a novel biomarker for detecting CAD.

Area of Science:

  • Cardiovascular Research
  • Molecular Biology
  • Genetics

Background:

  • The p66(shc) protein regulates cellular responses to oxidative stress and is implicated in atherosclerosis in animal models.
  • The association between p66(shc) gene expression and human coronary artery disease (CAD) has not been previously established.

Purpose of the Study:

  • To investigate whether p66(shc) gene expression is elevated in peripheral blood monocytes (PBMs) of patients with CAD compared to controls.
  • To determine if p66(shc) gene expression is an independent predictor of CAD.

Main Methods:

  • Quantitative real-time reverse transcription-polymerase chain reaction was used to measure p66(shc) gene expression levels in PBMs.
  • Uni- and multivariate analyses were performed to identify correlates of CAD in 40 Japanese subjects undergoing coronary angiography.
  • CAD was defined by >75% obstruction in a major coronary artery or prior percutaneous coronary intervention.

Main Results:

  • p66(shc) gene expression levels in PBMs were significantly higher in patients with CAD than in non-CAD subjects.
  • Multiple regression analysis indicated that p66(shc) gene expression and hypertension medication were independent predictors of CAD.
  • p66(shc) expression levels increased proportionally with the number of diseased coronary vessels.

Conclusions:

  • This study provides the first evidence that elevated p66(shc) gene expression in PBMs is independently associated with CAD in Japanese individuals.
  • p66(shc) gene expression in PBMs may represent a novel biomarker for the diagnosis of CAD in humans.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...